Date | Time | Source | Headline | Symbol | Company |
09/10/2024 | 3:00PM | iHub Newswire | FeaturedElement79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates | | |
01/20/2009 | 4:57PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
01/20/2009 | 8:51AM | Dow Jones News | Forest Labs Net Down 37% On Licensing Charge, Upgrades Fiscal Year View | NYSE:FRX | Forest Laboratories Inc. |
01/20/2009 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Q3'09 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Li | NYSE:FRX | Forest Road Acquisition Corp |
01/15/2009 | 1:52PM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Headline Stocks: LLY, PCS, CAG, FRX, TGT, DOW | NYSE:FRX | Forest Road Acquisition Corp |
01/15/2009 | 10:50AM | PR Newswire (US) | Seven Summits Research Releases Comments on VZ, UN, FRX, CVH, and ZION | NYSE:FRX | Forest Road Acquisition Corp |
01/14/2009 | 7:24PM | PR Newswire (US) | Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia | NYSE:FRX | Forest Road Acquisition Corp |
01/14/2009 | 7:24PM | PR Newswire (US) | Forest and Cypress Announce FDA Approval of Savella(TM) for the Management of Fibromyalgia | NYSE:FRX | Forest Road Acquisition Corp |
01/05/2009 | 5:00PM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Third Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
12/22/2008 | 8:00AM | PR Newswire (US) | Pierre Fabre Medicament and Forest Laboratories to Collaborate on Development and Commercialization of F2695 for Depression | NYSE:FRX | Forest Road Acquisition Corp |
12/17/2008 | 9:17AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/17/2008 | 9:03AM | PR Newswire (US) | Forest Laboratories Announces Executive Exercised Stock Options With Intent to Hold Shares | NYSE:FRX | Forest Road Acquisition Corp |
12/11/2008 | 2:38PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
12/10/2008 | 5:20PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:23PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/09/2008 | 4:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
12/08/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Manag | NYSE:FRX | Forest Road Acquisition Corp |
12/08/2008 | 8:00AM | PR Newswire (US) | Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Manag | NYSE:FRX | Forest Road Acquisition Corp |
12/03/2008 | 5:04PM | PR Newswire (US) | Forest Laboratories Responds To Unsolicited Mini-Tender Offer | NYSE:FRX | Forest Road Acquisition Corp |
11/24/2008 | 5:00PM | PR Newswire (US) | USPTO Confirms Validity of Bystolic(R) Patent | NYSE:FRX | Forest Road Acquisition Corp |
11/10/2008 | 4:08PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
10/27/2008 | 8:00AM | PR Newswire (US) | Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infecti | NYSE:FRX | Forest Road Acquisition Corp |
10/23/2008 | 8:00AM | PR Newswire (US) | Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes | NYSE:FRX | Forest Road Acquisition Corp |
10/21/2008 | 2:30PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |